The Progress

Milestones

  • 2020-2021

    Byonyks built its own production facility.

  • 2021

    Byonyks began treating patients (>1000 treatments)

  • 2022

    Established R&D centers in Chicago, US and Lahore, PK.

  • July 2023

    FiLab (France) biocompatibility tests approved.

  • September 2023

    HTW (China) electrical testing lab approved.

  • October 2023

    Byonyks got Official IEC certification from SGS (Geneva)

  • November 2023

    Byonyks completed human factor studies.

  • November 2023

    Byonyks got IEC approval from TUV SUD Minnesota.

  • November 2023

    Byonyks completed FDA Submission.